VYNE Therapeutics Inc【VYNE】 利益剰余金の推移

機能の使い方
(単位:千ドル) 利益剰余金 前年比(%)
1Q25 -739,800 +6.0%
4Q24 -731,200 +5.8%
3Q24 -719,100 +5.0%
2Q24 -707,000 +4.2%
1Q24 -697,600 +4.4%
4Q23 -691,300 +4.3%
3Q23 -685,100 +4.9%
2Q23 -678,600 +5.5%
1Q23 -668,500 +5.3%
4Q22 -662,700 +3.6%
3Q22 -652,800 +3.9%
2Q22 -643,300 +6.0%
1Q22 -634,900 +8.2%
4Q21 -639,525 +13.0%
3Q21 -628,000 +15.7%
2Q21 -606,700 +17.1%
1Q21 -586,700 +67.2%
4Q20 -566,200 +207.2%
3Q20 -543,000 +233.5%
2Q20 -518,300 +255.0%
1Q20 -350,861 +170.9%
4Q19 -184,339 +66.6%
3Q19 -162,841 +75.0%
2Q19 -145,986 +82.0%
1Q19 -129,509 +80.3%
4Q18 -110,636 +86.9%
3Q18 -93,042 -
2Q18 -80,194 -
1Q18 -71,848 -
4Q17 -59,191 -